Kenya has received Mpox testing kits and medicines for neglected tropical diseases (NTDs) from the World Health Organization (WHO), USAID, and other health partners.
The Ministry of Health says these supplies will strengthen the country’s efforts to combat these diseases.
During the handover, Cabinet Secretary for Health, Dr. Deborah M. Barasa, acknowledged the significance of these contributions in addressing health challenges faced by vulnerable communities.
She highlighted the importance of mass drug administration (MDA) campaigns in controlling NTDs, including lymphatic filariasis, soil-transmitted helminths, and schistosomiasis, particularly in high-burden regions.
Dr. Barasa expressed appreciation for the support from WHO and partners in ensuring essential medicines reach those most in need, with the upcoming MDA campaign targeting areas with the highest disease burden.
In addition, CS Barasa welcomed USAID’s donation of Mpox testing kits, which will improve the country’s ability to detect and respond to cases effectively.
WHO Representative to Kenya, Dr. Abdourahmane Diallo, confirmed the donation of 15,215,000 tablets of NTD medicines valued at USD 1.6 million, intended for this month’s MDA.
He reaffirmed WHO’s commitment to supporting Kenya’s goal of eliminating NTDs, including schistosomiasis and soil-transmitted helminthiases, by 2030.
